LETTERS FOR ISSUE ON
|
|
|
- Paul Floyd
- 5 years ago
- Views:
Transcription
1 S FOR ISSUE ON BE NOC FOR EXPORT S. NO. NAME OF THE COMPANY REF. NO. TYPE OF 1. M/S. ACCUTEST RESEARCH LABORATORIES (I) PVT., NAVI MUMBAI M/S. ACCUTEST RESEARCH LABORATORIES (I) PVT., NAVI MUMBAI M/S. ACTIMUS BIOSCIENCES PVT., VISAKHAPATNAM M/S. ALEMBIC PHARMACEUTICALS, VADODARA M/S. AMNEAL PHARMACEUTICALS COMPANY (I) PVT., AHMEDABAD M/S. APL RESEARCH CENTRE, AUROBINDO PHARMA, HYDERABAD M/S. APL RESEARCH CENTRE, AUROBINDO PHARMA, HYDERABAD M/S. BIO SCIENTIFIC RESEARCH LABORATORIES (INDIA) PVT., DIST. THANE M/S. BIOCON LIMITED, BANGALORE M/S. BIOCON LIMITED, BANGALORE M/S. BIOCON LIMITED, BANGALORE APPROVAL TEST LICENCE AMENDMENT TEST LICENCE CLARIFICATION AMENDMENT APPROVAL TEST LICENCE TEST LICENCE TEST LICENCE TEST LICENCE
2 12. M/S. CIPLA LIMITED, MUMBAI CLARIFICATION 13. M/S. CIPLA LIMITED, MUMBAI APPROVAL 14. M/S. CLIANTHA RESEARCH LIMITED, AHMEDABAD M/S. CLIANTHA RESEARCH LIMITED, AHMEDABAD M/S. CLIANTHA RESEARCH LIMITED, AHMEDABAD M/S. CLIANTHA RESEARCH LIMITED, AHMEDABAD M/S. DR. REDDY S LABORATORIES, HYDERABAD M/S. DR. REDDY S LABORATORIES, HYDERABAD M/S. DR. REDDY S LABORATORIES, HYDERABAD M/S. INVENTIA HEALTHCARE PVT., DIST. THANE M/S. JUBILANT GENERICS, NOIDA , UP 23. M/S. LAMBDA THERAPEUTIC RESEARCH, AHMEDABAD M/S. LIFESAN CLINICAL RESEARCH, MUMBAI M/S. LIFESAN CLINICAL RESEARCH, MUMBAI M/S. LOTUS LABS PVT., BANGALORE M/S. LOTUS LABS PVT., BANGALORE APPROVAL APPROVAL APPROVAL TEST LICENCE APPROVAL APPROVAL APPROVAL APPROVAL APPROVAL APPROVAL 6251 REJECTION APPROVAL APPROVAL AMENDMENT 28. M/S. LOTUS LABS PVT., APPROVAL
3 BANGALORE M/S. LOTUS LABS PVT., BANGALORE M/S. LUPIN LIMITED (RESEARCH PARK), 31. M/S. LUPIN LIMITED (RESEARCH PARK), 32. M/S. LUPIN LIMITED (RESEARCH PARK), 33. M/S. LUPIN LIMITED (RESEARCH PARK), 34. M/S. LUPIN LIMITED (RESEARCH PARK), 35. M/S. LUPIN LIMITED (RESEARCH PARK), 36. M/S. LUPIN LIMITED (RESEARCH PARK), 37. M/S. RAPTIM RESEARCH, NAVI MUMBAI M/S. SUN PHARMACEUTICAL INDUSTRIES, VADODARA M/S. SYNCHRON RESEARCH SERVICES PVT., AHMEDABAD M/S. SYNGENE INTERNATIONAL, BANGALORE M/S. UNICHEM LABORATORIES, MUMBAI M/S. VEEDA CLINICAL RESEARCH PVT., AHMEDABAD M/S. VEEDA CLINICAL RESEARCH PVT., AHMEDABAD M/S. VEEDA CLINICAL RESEARCH PVT., AHMEDABAD TEST LICENCE APPROVAL APPROVAL APPROVAL APPROVAL APPROVAL APPROVAL APPROVAL APPROVAL 9706/9707 CLARIFICATION APPROVAL TEST LICENCE TEST LICENCE APPROVAL APPROVAL TEST LICENCE
4 45. M/S. VIMTA LABS, HYDERABAD M/S. VIMTA LABS, HYDERABAD M/S. WATSON PHARMA PVT., NAVI MUMBAI M/S. WATSON PHARMA PVT., NAVI MUMBAI M/S. WATSON PHARMA PVT., NAVI MUMBAI M/S. WOCKHARDT LIMITED, AURANGABAD APPROVAL APPROVAL ADDITIONAL STUDY CENTRE APPROVAL APPROVAL APPROVAL LVP DIVISION S. NO. COMPANY NAME FTS NO. /DIARY NO. STATUS 01 M/S. CURE LIFE CARE PVT., GUJARAT 02 M/S. AMANTA HEALTHCARE, GOA 03 M/S. INTAS PHARMACEUTICALS, C/O. M/S. AMANTA HEALTHCARE, GUJARAT 04 M/S. RAPTAKOSS BRETT & CO, C/O. M/S. DENIS CHEM, GUJARAT QUERY APPROVAL APPROVAL APPROVAL COSMETIC DIVISION S.NO. COMPANY NAME DIARY NO STATUS 1. M/S. CHANEL (INDIA) PRIVATE LIMITED, MUMBAI 11001, APPROVAL 2. M/S. AERO PHARMA (SILVASSA) APPROVAL 3. M/S. SIBERTIAN HEALTH INTERNATIONAL PVT. LTD, NEW DELHI APPROVAL
5 4. M/S. EKTA COSMETICS LTD, NEW DELHI DEFICIENCY 5. M/S. BLUE STAR TRADERS, KERALA DEFICIENCY 6. M/S. ROTARY INTERNATIONAL, JHARKHAND DEFICIENCY 7. M/S. BELLE VOUS PRIVATE NEW DELHI DEFICIENCY 8. M/S. BACCAROSE PERFUMES & BEAUTY PRODUCTS PVT. LTD, APPROVAL MUMBAI 9. M/S. OCEA MARINE COSMETICS PVT. LTD, MUMBAI DEFICIENCY 10. M/S. PERFECT WAY TRADING, MUMBAI 8017 APPROVAL 11. M/S. PFIZER LIMITED, MUMBAI APPROVAL 12. M/S. NIVEA INDIA PVT. LTD, MUMBAI APPROVAL 13. M/S. MYRAH SPA & PRODUCTS PVT. LTD, MUMBAI APPROVAL 14. M/S. COLGATE PALMOLIVE( INDIA) LIMITED, MUMBAI APPROVAL 15. M/S. INDITEX TRENT RETAIL INDIA PRIVATE LIMITED, HARYANA APPROVAL 16. M/S. GARDENIA COSMOCARE PVT. LTD, MUMBAI APPROVAL 17. M/S. G.S. PHARMABUTOR PVT. LTD, APPROVAL UTTARAKHAND 18. M/S. JCKRC SPA DESTINATION PVT. LTD, MUMBAI APPROVAL IMPORT S.NO. NAME OF APPLICANT DIARY NO. TYPE OF 1. DSM SINOCHEM AMENDED REGISTRATION S.NO. NAME OF APPLICANT DIARY NO. TYPE OF 1. ESSCHEM P APPROVAL 2. SHAH TC APPROVAL 3. ANANTCO ENTERPRISES PVT. 4. ACERBRIGHT INDIA PHARMA PVT AMENDED AMENDED
6 5. CHEMET OF SPAN 3038 CLARIFICATION 6. ETHACHEM 2032 CLARIFICATION 7. ASTELLAS PHARMA INDIA PV.T CLARIFICATION 8. UNI-CHEMIE INTERNATIONAL 47774, CLARIFICATION 9. ARUN & CO, CLARIFICATION 10. FERTIN INDIA PVT CLARIFICATION 11. JOHNSON & JOHNSON 5121 CLARIFICATION NEW DRUG S.NO. NAME OF APPLICANT DIARY TYPE OF NO. 1. M/S. SUN PHARMACEUTICALS - INDUSTRIES LIMITED 2. M/S CIPLA LTD - MEETING NOTICE (PULMONARY) MEDICAL DEVICE S.NO. COMPANY NAME DIARY NO STATUS 1. M/S. COVIDIEN HEALTHCARE INDIA PVT. 2. M/S. COVIDIEN HEALTHCARE INDIA PVT APPROVAL (R- RC) 9242 APPROVAL (R-IL) 3. M/S. JOHNSON & JOHNSON PRIVATE 8410 APPROVAL (R- RC) 4. M/S. JOHNSON & JOHNSON PRIVATE 8410 APPROVAL (R-IL) 5. M/S. JOHNSON & JOHNSON PRIVATE 9209 APPROVAL (R- RC) 6. M/S. JOHNSON & JOHNSON PRIVATE 9209 APPROVAL (R-IL) 7. M/S. JOHNSON & JOHNSON PRIVATE 8020 APPROVAL (R-
7 RC) 8. M/S. JOHNSON & JOHNSON PRIVATE 8020 APPROVAL (R-IL) 9. M/S. JOHNSON & JOHNSON PRIVATE 8411 APPROVAL (R- RC) 10. M/S. JOHNSON & JOHNSON PRIVATE 8411 APPROVAL (R-IL) 11. M/S. LAKSHMI LIFE SCIENCES LIMITED CLARIFICATION 12. M/S. INNVOLUTION HEALTHCARE PRIVATE LIMITED APPROVAL (E-IL) 13. M/S. JOHNSON & JOHNSON PRIVATE 4627 AMENDMENT 14. THE COMMISSIONER, FDA, GANDHINAGAR (CLAA) THE DEPUTY DRUGS CONTROLLER(I), CDSCO AHMADABAD M/S. POLYMER TECHNOLOGY INTERNATIONAL(EOU) 15. THE STATE DRUGS CONTROLLER, FDA PUNCHKULA (CLAA), THE DEPUTY DRUGS CONTROLLER(I), CDSCO, HAPUR M/S. MECMAAN HEALTHCARE PVT. 16. THE STATE DRUGS CONTROLLER, FDA PUNCHKULA (CLAA), THE DEPUTY DRUGS CONTROLLER(I), CDSCO, HAPUR M/S. HOLLISTER INDIA PRIVATE LIMITED FTS FTS FTS QUERY QUERY APPROVAL 17. M/S. SMITH AND NEPHPEW HEALTHCARE PVT. 18. M/S. SMITH AND NEPHPEW HEALTHCARE PVT APPROVAL(E-RC) 8512 APPROVAL(E-IL) 19. M/S. GALDERMA INDIA PVT. FTS CLARIFICATION
8 20. M/S. RANBAXY LABORATORIES 3597 APPROVAL (TL) 21. M/S. BOSTON SCIENTIFIC INDIA PVT QUERY 22. M/S. BOSTON SCIENTIFIC INDIA PVT. FTS QUERY 23. M/S. INDIA MEDTRONIC PVT APPROVAL 24. M/S EDWARDS LIFESCIENCES (INDIA) PVT APPROVAL 25. M/S. MERI LIFE SCIENCES PVT DIAGNOSTICS DIVISION S.NO. COMPANY NAME DIARY NO STATUS 1. M/S. ARKRAY HEALTHCARE PVT APPROVAL (IL) 2. M/S. ARKRAY HEALTHCARE PVT APPROVAL (IL) 3. M/S. BECKMAN COULTER INDIA PRIVATE LIMITED 4. M/S. BIO-RAD LABORATORIES (INDIA) PVT. 5. M/S. BIO-RAD LABORATORIES (INDIA) PVT. 6. M/S. BIO-RAD LABORATORIES (INDIA) PVT APPROVAL (IL) 9153 APPROVAL (R-RC) 9153 APPROVAL (R-IL) 9153 QUERY 7. M/S. ARK DIAGNOSTIC SYSTEM PVT QUERY 8. M/S. JOHNSON & JOHNSON PRIVATE APPROVAL (E-IL) 9. M/S. ROCHE DIAGNOSTICS INDIA PVT CLARIFICATION
LETTERS FOR ISSUE ON
S FOR ISSUE ON 14.03.2016 IMPORT S.NO. NAME OF APPLICANT DIARY NO. TYPE OF 1. TABLETS (INDIA) LIMITED 5973 APPROVAL 2. TABLETS (INDIA) LIMITED 5974 APPROVAL 3. CLARIS OTSUKA PRIVATE LIMITED 7373 APPROVAL
LETTERS FOR ISSUE ON
S FOR ISSUE ON 05.10.2015 INTERNATIONAL CELL S. NO FIRM NAME TYPE OF DOCUMENT 1. M/S. ARRIGO INTERNATIONAL,INDORE 2 M/S. EUROLIFE HEALTHCARE PVT. LTD. HARIDWAR NEW DRUG S. NAME OF APPLICANT DIARY TYPE
LETTERS FOR ISSUE ON
S FOR ISSUE ON 17.07.2015 NEW DRUG S.NO. NAME OF APPLICANT DIARY TYPE OF NO. 1. M/S. CIREX PHARMACEUTICALS LTD - QUERY 2. M/S. LUPIN LIMITED - ADDITIONAL SITES REGISTRATION S.NO. NAME OF APPLICANT DIARY
LETTERS FOR ISSUE ON
S FOR ISSUE ON 14.12.2015 LVP DIVISION S. COMPANY NAME FTS /DIARY STATUS 01 M/S. AXA PARENTERALS LTD., ROORKEE 60262 APPROVAL 02 M/S. UNIJULES LIFE SCIENCES LTD., NAGPUR 61147 APPROVAL 03 M/S. INNVOL MEDICAL
LETTERS FOR ISSUE ON
S FOR ISSUE ON 17.05.2016 BE NOC FOR EXPORT S. NO. NAME OF THE COMPANY REF. NO. TYPE OF 1. M/S. ACCUTEST RESEARCH MUMBAI-400709 2. M/S. ACCUTEST RESEARCH MUMBAI-400709 3. M/S. ACCUTEST RESEARCH MUMBAI-400709
LETTERS FOR ISSUE ON
S FOR ISSUE ON 04.12.2015 NEW DRUG S.NO. NAME OF APPLICANT DIARY NO. TYPE OF 1. M/S. VIRCHOW BIOTECH PVT LTD - QUERY 2. M/S. MSN LABORATORIES PVT - CT-NOC & BE NOC LTD (3) 3. M/S. NATCO PHARMA LTD. - BE-NOC
LETTERS FOR ISSUE ON
S FOR ISSUE ON 21.06.2016 LVP DIVISION S. NO. COMPANY NAME FTS NO. /DIARY NO. STATUS 01 M/S. GLOBAL PHARMA HEALTHCARE PVT. LTD., THIRUPORUR 27509 APPROVAL BIOLOGICAL DIVISION NAME OF COMPANY DY.NO. STATUS
LETTERS FOR ISSUE ON
S FOR ISSUE ON 03.09.2015 INTERNATIONAL CELL S. NO FIRM NAME TYPE 1. M/S LUPIN TARAPUR, MAHARASHTRA & WC 2. M/S JPN PHARMA PVT. PALGHAR, MAHARASHTRA WC 3. M/S OPTIMUS DRUGS A.P. WC VACCINE DIVISION S.
LETTERS FOR ISSUE ON
S FOR ISSUE ON 04.10.2017 MEDICAL DEVICE DIVISION S.NO. COMPANY NAME DIARY NO STATUS 1. M/S. ABBOTT MEDICAL OPTICS PVT. LTD., 14608 QUERY 2. M/S. ABBOTT MEDICAL OPTICS PVT. LTD., 14609 QUERY 3. DR. ULHAS
LETTERS FOR ISSUE ON
S FOR ISSUE ON 11.04.2017 BIOLOGICAL DIVISION NAME OF COMPANY DY. NO. STATUS M/S ZUVENTUS HEALTHCARE LTD 6981 APPROVAL M/S TECHINVENTION LIFE SCIENCES 1208 CLARIFICATION M/S CADILA PHARMACEUTICALS LTD
LETTERS FOR ISSUE ON
S FOR ISSUE ON 25.04.2017 BE NOC FOR EXPORT S. NO. NAME OF THE COMPANY REF. NO. TYPE OF 1. M/S. ALEMBIC PHARMACEUTICALS 2. M/S. ALEMBIC PHARMACEUTICALS 3. M/S. ALEMBIC PHARMACEUTICALS 4. M/S. EMCURE PHARMACEUTICALS
LETTERS FOR ISSUE ON
S FOR ISSUE ON 15.10.2015 INTERNATIONAL CELL S. NO FIRM NAME TYPE 1 M/S NATCO PHARMA LIMITED HYDERABAD MEDICAL DEVICE S.NO. COMPANY NAME DIARY NO STATUS 1. M/S. GENETIX BIOTECH ASIA PVT. LTD. 22073 APPROVAL
LETTERS FOR ISSUE ON
S FOR ISSUE ON 29.11.2016 COSMETICS DIVISION S.NO. NAME OF APPLICANT DIARY NO. TYPE OF 1. M/S. WELLA INDIA PVT. LTD., MUMBAI 29233, 29524 & 28513 APPROVAL 2. M/S. PROCTER & GAMBLE HOME PRODUCTS PVT. LTD.,
LETTERS FOR ISSUE ON
S FOR ISSUE ON 01.09.2015 INTERNATIONAL CELL S. NO FIRM NAME TYPE 1. M/S TYCHE INDUSTRIES LTD., ANDHRA PRADESH, INDIA IMPORT S. NAME OF APPLICANT DIARY TYPE OF 1. PIRAMAL ENTERPRISES LTD. 25471 APPROVAL
TODAY LETTER DATED
TODAY LETTER DATED 26.06.2018 GLOBAL CLINICAL TRIAL SR. NO. COMPANY NAME REFERENCE NO. STATUS 1 M/S. RESEARCH ASSOCIATES INDIA PVT.. 18670 PA APPROVAL LETTER LVP DIVISION S. NO. COMPANY NAME FTS NO. /DIARY
LETTERS FOR ISSUE ON
LETTERS FOR ISSUE ON 27.12.2017 LVP DIVISION S. NO. COMPANY NAME FTS NO. /Diary No. STATUS 01 M/s. Akums Drugs & Pharmaceuticals, Haridwar 02 M/s. Unique Pharmaceutical Laboratories,Guj. (License No.4)
LETTERS FOR ISSUE ON
S FOR ISSUE ON 27.08.2015 NEW DRUG S. NAME OF APPLICANT DIARY TYPE OF 1. M/S. INTAS PHARMACEUTICALS LIMITED - CT NOC (2) 2. M/S. PFIZER LIMITED - QUERY 3. M/S. MSN LABORATORIES - ADDITIONAL SITE 4. M/S.
File no./drug Name Name of firm/ Institute Recommendations. New Drugs Division
Recommendations: I approve the minutes of 52 nd SEC (Oncology & hematology) held on 13.04.2017 at CDSCO HQ New Delhi and recommended the following: Agenda 1 12-63/16-DC Ferric Pyrophosphate citrate solution
Recommendations of thesec (Dermatology & Allergy) made in its 23 rd meeting held on at CDSCO HQ New Delhi: New Drugs Division
Recommetions of thesec (Dermatology & Allergy) made in its 23 rd meeting held on 11.05.2017 at CDSCO HQ New Delhi: File /Drug Name Recommetions New Drugs Division 1 12-28/15-DC (Pt-B) Apremilast 10/20/30
RESULTS AND DISCUSSION
RESULTS AND DISCUSSION 203 4.1 General Introduction: The researcher has collected both the primary and secondary data. The primary data is collected by direct interaction by using formal questionnaire
ORDER. Table. (1) (2) (3) (4) (5) (6) 1. Glimepiride Metformin Tablet
(Published in Part II, Section 3, Sub-section (ii) of the Gazette of India, Extraordinary) Government of India Ministry of Chemicals and Fertilizers Department of National Pharmaceutical Pricing Authority
TRADE MARKS REGISTRY AHMEDABAD
TRADE MARKS REGISTRY AHMEDABAD OPPOSITION HEARING LIST FOR THE MONTH OF SPTEMBER-2013 DATE OF HEARING 10.09.2013 R. T. M. 1. 842945/16 Rect. AMD-249059 Mr. Pankajbhai Sitaram Nayak, Hearing on Section
3. Dr.Rajutitus Chacko, Prof. & Head, Dept. of Medical Oncology, CMC, Vellore.
MINUTES OF THE 6 th MEETING OF TECHNICAL COMMITTEE HELD ON 25-07-2013 UNDER CHAIRMANSHIP OF DGHS FOR SUPERVISING CLINICAL TRIALS ON NEW CHEMICAL ENTITIES IN THE LIGHT OF DIRECTIONS OF THE HON BLE SUPREME
Companies Database, Mobile Database, Id Database, Credit
m All India Database We Provides Database Companies Database, Mobile Database, Email Id Database, Credit Card Holder Database, Corporate database, CEO s Database, Corporate Employee Database, Car s Owner
Education. Current Activities
Nirali Mehta, M.Sc., M.Phil. Founder & Consultant Biostatistician Ahmedabad, Gujarat, India. M +91 9377060504 E nirali.mehta@pharma-stats.in W www.pharma-stats.in Education 1998-2001 Bachelor of Science
Solvay in India January, 2014
Solvay in India January, 2014 SOLVAY in India, Innovation and Operational excellence Jodhpur Hichem (JV) Ahmedabad Hichem (JV) Bhiwani Hichem (JV) Delhi Hichem (JV) Solvay R&D center Vadodara Panoli Solvay
Doing Business in India; Nutritional ingredients supplier perspective. Jaime Piza DSM Nutritional Products November, 2012
Doing Business in India; Nutritional ingredients supplier perspective Jaime Piza DSM Nutritional Products November, 2012 Table of contents Doing business IFC classification. Still some hurdle to take...
Case 1:14-cv LPS Document 195 Filed 01/05/16 Page 1 of 5 PageID #: 6023
Case 1:14-cv-00121-LPS Document 195 Filed 01/05/16 Page 1 of 5 PageID #: 6023 IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE FOREST LABO RA TORIES, INC., FOREST LABO RA TORIES HOLDINGS,
Minimumum Price (Rs.) 3.30 Maximum Price (Rs.) 4.57 Average of all considered (Rs.) 3.73 Retail Price (Rs.) 4.33
Computataion of Retail Price based on Jan.-2016 Data under Para 4 of DPCO 2013 Cholecalciferol 800 IU Drops of M/s Raptakos, Brett & Co.Ltd. Number of Companies cosisting of Market Share of 1% & Above
TOTAL MAT 1,52,81, % Unit PTR (Rs.) MAT (Rs.) SKU wise MAT % प क व रण Pack Description छ प BRAND. क पन Company. S. No. Unique No.
Number of Companies consisting of Market Share of 1% & Above 2 3.1 Adrenaline Injection 1 mg/ml Per ml Sum of MAT value considered for price calculation (in Lakhs) 152.69 Sum of PTR per unit considered
Case 3:15-cv PGS-TJB Document 1 Filed 08/04/15 Page 1 of 111 PageID: 1 ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) )
Case 3:15-cv-05982-PGS-TJB Document 1 Filed 08/04/15 Page 1 of 111 PageID: 1 Liza M. Walsh Christine I. Gannon CONNELL FOLEY LLP One Newark Center 1085 Raymond Boulevard, 19th Floor Newark, New Jersey
TRADE MARKS REGISTRY AHMEDABAD
TRADE MARKS REGISTRY AHMEDABAD OPPOSITION HEARING LIST FOR THE MONTH OF JUNE-2016 DATE OF HEARING 13.06.2016 1. 934855/05 Opp. AMD-245342 M/s. Ajanta Pharma Limited, Mumbai / Mr. Manoj G. Menda, Mumbai
10 th SEC- (Reproductive & Urology)meetingheld on at CDSCO (HQ), FDA Bhawan, Kotla road, New Delhi PROGRAMME SCHEDULE
10 th SEC- (Reproductive & Urology)meetingheld on 16-01-2015 at CDSCO (HQ), FDA Bhawan, Kotla road, New Delhi 110 002 PROGRAMME SCHEDULE Recommendation:- The 10 th SEC (Reproductive and Urology) meeting
+91-8048762617 Innovexia Life Sciences Private Limited http://www.innovexia.in/ We are a renowned organization, which is engaged in manufacturing, supplying, trading and wholesaling a wide range of Pharmaceutical
Country Coverage. Company Coverage
Global Heart Valve Devices Market: Analysis By Procedure (Replacement & Repair), Replacement Procedure By Technique (Mechanical, Bioprosthetic & TAVR), Repair Procedure By Technique (Surgical, Balloon
Ameya works predominantly in the architectural design, interiors and project management segments in healthcare industry
Introduction Ameya design is premier health care consultancy firm with experience with design and execution of largest number of private sector health care facility in India. Key Information Ameya works
Global Aspergillosis Drugs Market Professional Survey Report 2016
Report Information More information from: https://www.wiseguyreports.com/reports/526011 Global Aspergillosis Drugs Market Professional Survey Report 2016 Report / Search Code: WGR526011 Publish Date: 24
Information for Vermont Prescribers of Prescription Drugs Long Form
Information for Vermont Prescribers of Prescription Drugs Long Form Pylera (bismuth subcitrate potassium, metronidazole, and tetracycline hydrochloride) Capsules The prices listed below are Average Wholesale
REGULATORY UPDATES: APPROVAL, DENIALS AND AGREEMENTS REGULATORY UPDATES: APPROVAL, (CONTINUED)... 38
CHAPTER ONE: INTRODUCTION... 1 STUDY OBJECTIVES... 1 REASONS FOR DOING THIS STUDY... 1 INTENDED AUDIENCE... 2 SCOPE OF THE STUDY... 2 METHODOLOGY... 2 INFORMATION SOURCES... 2 ABOUT THE AUTHOR... 3 RELATED
New Drugs Division. Frequently Asked Questions (FAQs) on Approval of new Phytopharmaceutical Drugs
Central Drugs Standard Control Organization Directorate General of Health Services Ministry of Health and Family Welfare Government of India New Drugs Division Frequently Asked Questions (FAQs) on Approval
Information for Vermont Prescribers of Prescription Drugs
Information for Vermont Prescribers of Prescription Drugs ZOLOFT (sertraline hydrochloride) tablets, for oral use This list does not imply that the products on this chart are interchangeable or have the
MEETING OF DRUGS TECHNICAL ADVISORY BOARD HELD ON 1 ST APRIL, 2014 IN THE CHAMBER OF DGHS, NIRMAN BHAWAN, NEW DELHI
MINUTES OF THE 67 TH MEETING OF DRUGS TECHNICAL ADVISORY BOARD HELD ON 1 ST APRIL, 2014 IN THE CHAMBER OF DGHS, NIRMAN BHAWAN, NEW DELHI PRESENT 1. Dr. Jagdish Prasad, Chairman Director General of Health
Global Vitamin Market Professional Survey Report 2016
Published on Market Research Reports Inc. (https://www.marketresearchreports.com) Home > Global Vitamin Market Professional Survey Report 2016 Global Vitamin Market Professional Survey Report 2016 Publication
Information for Vermont Prescribers of Prescription Drugs Long Form Fetzima (levomilnacipran) Extended Release Capsules
Information for Vermont Prescribers of Prescription Drugs Long Form Fetzima (levomilnacipran) Extended Release Capsules The prices listed below are Average Wholesale Prices ( AWP ) as established and made
https://www.indiamart.com/max-pharma/
+91-8048603315 Max Pharma https://www.indiamart.com/max-pharma/ We are one of the leading organizations engaged in manufacturing and supplying a wide range of Pharmaceutical Drugs. These include Tablets,
INDICATIVE SEAT MATRIX - NBE FET CENTRALIZED COUNSELING 2016 ADMISSION SESSION ROUND-2
G B Pant Hospital J L Nehru Marg, Delhi Cardiac Anaesthesia 1 Delhi-110002 Indraprastha s Delhi Cardiac Anaesthesia 1 Medanta- The Medicity Sector-38, Gurgaon, Haryana Cardiac Anaesthesia 5 Haryana-122001
PHARMACEUTICALS EXPORT PROMOTION COUNCIL OF INDIA
Disbursement of MDA Claims to Individual Exporters during (-11) 1 JPN Pharma API China 80,000.00 2 Unique Biotech Limited Bio May 3-6, 80,000.00 3 Titan Biotech Limited Cphi Japan 21st to 23rd April 80,000.00
PDF of Trial CTRI Website URL -
Clinical Trial Details (PDF Generation Date :- Sun, 02 Sep 2018 23:38:24 GMT) CTRI Number Last Modified On 05/02/2015 Post Graduate Thesis Type of Trial Type of Study Study Design Public Title of Study
Workshop on Review Procedure Adopted for Evaluation of New Drug Application, BA/ BE Study and Marketing Permission from 24 th 27 th February, 2014 at
Workshop on Review Procedure Adopted for Evaluation of New Drug Application, BA/ BE Study and Marketing Permission from 24 th 27 th February, 2014 at New Delhi Objective of the Workshop The primary objective
Tamsulosin Hydrochloride 0.4 mg Capsule
Tamsulosin Hydrochloride 0.4 mg Capsule, Tamsulosin Hydrochloride 0.4 mg Capsule India, Tamsulosin Hydrochloride 0.4 mg Capsule manufacturers India, side effects Tamsulosin Hydrochloride 0.4 mg Capsule
PHARMACEUTICALS EXPORT PROMOTION COUNCIL OF INDIA
1 Agio Pharmaceuticals Limited 15/31/2013-EP(Engg) dt:21.11.2013 7,98,217.00 2 Akriti Pharmaceuticals Pvt Ltd 15/31/2013-EP(Engg) dt:21.11.2013 15,10,268.00 3 Akriti Pharmaceuticals Pvt Ltd 15/31/2013-EP(Engg)
Edmund Healthcare Pvt. Ltd.
+91-8048410921 Edmund Healthcare Pvt. Ltd. https://www.edmundhealthcare.in/ Our firm is ranked as the leading Trader and Supplier of a wide array of Pharmaceutical Injection, Pharmaceutical Tablets, Pharmaceutical
MINISTRY OF HEALTH, COMMUNITY DEVELOPMENT, GENDER, ELDERY & CHILDREN TANZANIA FOOD AND DRUGS AUTHORITY P.O.
MINISTRY OF HEALTH, COMMUNITY DEVELOPMENT, GENDER, ELDERY & CHILDREN TANZANIA FOOD AND DRUGS AUTHORITY P.O. Box 1253, Dodoma, Tanzania Tel: +255 22 2450751, +255 22 2450512, Fax: +255 22 2450793 Website:
Recent trends and challenges
INTERNATIONAL CONFERENCE ON Recent trends and challenges in Bioanalysis Tentative Program Bioanalytica-2017 Hyderabad,India JUNE 30, 2017 Invitation ABC Biologics welcomes you to attend the international
Excipient Regulations Perspective & Creation of IPEC India (Current Regulations & Emerging challenges for excipient regulations in India)
INTERNATIONAL PHARMACEUTICAL EXCIPIENTS COUNCIL OF INDIA (IPEC INDIA) Excipient Regulations Perspective & Creation of IPEC India (Current Regulations & Emerging challenges for excipient regulations in
BRIC DIABETES DRUGS MARKET
BRIC DIABETES DRUGS MARKET R e p o r t D e s c r i p t i o n T a b l e o f C o n t e n t s L i s t o f T a b l e s S a m p l e T a b l e s R e l a t e d R e p o r t s A b o u t M a r k e t s a n d M a
Status of Import License (Form 10) of Recombinant Products, Human and Veterinary Vaccines issued from 01/03/2016 to 29/04/2016
1. M/s LG Life Sciences India Pvt. Ltd.,Basement Commercial SCO No. 321, Sector-29, Gurgaon, India 2. M/s Eli Lilly and Co (I) Pvt. Ltd., Bldg. No. 14, Gala No. 1 to 4, 1 st Fl, Arihant Comm. Complex,
Regulatory Reforms-Future of Plasma Protein Therapy in India
Regulatory Reforms-Future of Plasma Protein Therapy in India Ranjeet S. Ajmani PlasmaGen BioSciences Pvt. Ltd. Bangalore, India PPB-2013 Price Tag of Contrast q Uniqueness q Co-existence : Rich & Poor
CHAPTER FOUR: UPDATE ON THE AIDS PANDEMIC TABLE 2 MILESTONES IN THE HISTORY OF HIV/AIDS TABLE 2 (CONTINUED) REGIONAL OVERVIEW...
CHAPTER ONE: INTRODUCTION... 1 STUDY GOALS AND OBJECTIVES... 1 REASONS FOR DOING THE STUDY... 1 SCOPE OF REPORT... 1 MARKET ANALYSES AND FORECASTS... 2 INTENDED AUDIENCE... 2 INFORMATION SOURCES... 2 ANALYST
Fluid Flow Calibration Facilities in India- A Case Study
flotek.g 2017- Innovative Solutions in Flow Measurement and Control - Oil, Water and Gas August 28-30, 2017, FCRI, Palakkad, Kerala, India Fluid Flow Calibration Facilities in India- A Case Study Battal
Exporting Heart Disease to Developing Countries: India. Zeeshan Ali, Ph.D.
Exporting Heart Disease to Developing Countries: India Zeeshan Ali, Ph.D. Mortality Rate Heart disease is the number one cause of mortality. Accounts for one-fourth of all deaths in India. Source: Gupta
New Delhi, the 18 th December, 2017 ORDER
(Published in Part II, Section 3, Sub-section (ii) of the Gazette of India, Extraordinary) Government of India Ministry of Chemicals and Fertilizers Department of National Pharmaceutical Pricing Authority
Information for Vermont Prescribers of Prescription Drugs
Information for Vermont Prescribers of Prescription Drugs LIPITOR (atorvastatin calcium) tablets This list does not imply that the products on this chart are interchangeable or have the same efficacy or
DR. P. V. APPAJI M.Pharm, Ph.D EXECUTIVE DIRECTOR
Date: 7 th July 2006 Dehradun PRESENTATION BY DR. P. V. APPAJI M.Pharm, Ph.D EXECUTIVE DIRECTOR PHARMACEUTICALS EXPORT PROMOTION COUNCIL PHARMACEUTICALS EXPORT PROMOTION COUNCIL SET UP BY MINISTRY OF COMMERCE
ORDER. Table. Retail Price (Rs.) (1) (2) (3) (4) (5) (6) 1. Rosuvastatin + Clopidogrel Capsule (Crevast CV 20)
(Published in Part II, Section 3, Sub-section (ii) of the Gazette of India, Extraordinary) Government of India Ministry of Chemicals and Fertilizers Department of Pharmaceuticals National Pharmaceutical
UN Panel Discussion Millennium Development Goals. Ajay Singh Senior Director Dr Reddy s Laboratories 07 July 2010
UN Panel Discussion Millennium Development Goals Ajay Singh Senior Director Dr Reddy s Laboratories 07 July 2010 1 A role for everyone. North Large branded companies Strong engine of innovation Almost
Status of Registration Certificate (Form 41) of Human Vaccines issued from 01/03/2015 to 29/05/2015. Human vaccines
Status of Registration Certificate (Form 41) of Human Vaccines issued from 01/03/2015 to 29/05/2015 S. No. Firm Name of Formulation Registration Certificate No. & Validity 1. M/s. Nirlac Chemicals,14 th
Nitrazepam. Nitrazepam Tablets TAJ GROUP PHARMACEUTICAL B U S I N E S S. Generics. Active Ingredients: Each tablet contains 10 mg Nitrazepam
Nitrazepam, Nitrazepam India, Nitrazepam manufacturers India, side effects Nitrazepam manufacturers, Taj Pharma India, Nitrazepam overdose, Nitrazepam drug, Nitrazepam composition, Manufacturing Pharmaceutical,
INTRAVENOUS (IV) THERAPY AND VEIN ACCESS: GLOBAL MARKETS
INTRAVENOUS (IV) THERAPY AND VEIN ACCESS: GLOBAL MARKETS HLC046C November 2014 Mary C. Patton Project Analyst ISBN: 1-56965-982-6 BCC Research 49 Walnut Park, Building 2 Wellesley, MA 02481 USA 866-285-7215
PDF of Trial CTRI Website URL -
Clinical Trial Details (PDF Generation Date :- Fri, 05 Oct 2018 20:16:50 GMT) CTRI Number Last Modified On 07/08/2014 Post Graduate Thesis Type of Trial Type of Study Study Design Public Title of Study
REF/2012/01/ CTRI Website URL -
Clinical Trial Details (PDF Generation Date :- Sat, 05 May 2018 05:20:32 GMT) CTRI Number Last Modified On 06/04/2015 Post Graduate Thesis Type of Trial Type of Study Study Design Public Title of Study
Information for Vermont Prescribers of Prescription Drugs
Information for Vermont Prescribers of Prescription Drugs ARTHROTEC (diclofenac sodium/misoprostol) tablets This list does not imply that the products on this chart are interchangeable or have the same
ii. To support India s trade-related training institutions in strengthening their capacities.
EU-India Capacity Building Initiative for Trade Development in India - CITD INSTITUTIONAL SUPPORT AND TRAINING REGARDING THE EU DIRECTIVE 2004/24/EC ON HERBAL MEDICINES 0. INTRODUCTION The Project (EU-India
AGENDA PAPERS FOR THE EIGHTEENTH MEETING SUB-COMMITTEE ON LARGE ANIMALS (SCLA)
AGENDA PAPERS FOR THE EIGHTEENTH MEETING OF SUB-COMMITTEE ON LARGE ANIMALS (SCLA) DATE : 18.04.2005 TIME : 3 : 00 P.M. VENUE : 8 TH FLOOR, JEEVAN PRAKASH BUILDING, 25, KASTURBA GANDHI MARG, NEW DELHI.
PDF of Trial CTRI Website URL -
Clinical Trial Details (PDF Generation Date :- Sat, 17 Nov 2018 21:22:46 GMT) CTRI Number Last Modified On 29/08/2012 Post Graduate Thesis Type of Trial Type of Study Study Design Public Title of Study
CNBC TV 18 Electronic, National September 19, 2013
CNBC TV 18 Electronic, National September 19, 2013 http://www.moneycontrol.com/news/cnbc tv18 comments/jj toresume ops at mulund plant after hc reprieve _953010.html PTI Online September 19, 2013 HC relief
REF/2014/04/ CTRI Website URL -
Clinical Trial Details (PDF Generation Date :- Wed, 02 May 2018 19:38:55 GMT) CTRI Number Last Modified On 13/12/2014 Post Graduate Thesis Type of Trial Type of Study Study Design Public Title of Study
Hyderabad, India Delegates. April 27, Tentative program A comprehensive Bioanalysis conclave. Key notes.
INTERNATIONAL CONFERENCE &EXHIBITION Tentative program A comprehensive Bioanalysis conclave 7+ Key notes 50+ Poster presentations 100+ Delegates 2 + Panel Discussions April 27, 2018 Hyderabad, India Invitation
A study on Metformin (1, 1-Dimethylbiguanidemonohydrochloride) reported adverse events as observed in Eudravigilance database
A study on Metformin (1, 1-Dimethylbiguanidemonohydrochloride) reported adverse events as observed in Eudravigilance database Contract Research Organization / Terzetto Pharma Metrics NIVETHA CHELLAPATHY
Global Transcatheter Mitral Valve Repair and Replacement (TMVR) Market: Analysis By Region, By Country: Opportunities and Forecast ( )
Global Transcatheter Mitral Valve Repair and Replacement (TMVR) Market: Analysis By Region, By Country: Opportunities and Forecast (2017-2022) By Region- North America, Europe, APAC and RoW By Country
Narcotics Control Bureau
Narcotics Control Bureau 2 MARCH - 2015 MARCH - 2015 3 Narcotics Control Bureau SN Date Zone/Sub Zone Drug Seized Qty.(Kg) Indians Arrested 1 31.01.2015 Ahmedabad Alprazolam tab 272.522 Methylphenidate
New: Li st of TPAs List of TPA's released by IRDA Updated C on Oct lick Here.
TPA List In India // Third Party Administrators for Health Insurance are a link between the insured A Third Party Administrator is the same as an ASO - administrative services only company. The duties
WHO PUBLIC INSPECTION REPORT (WHOPIR) Contract Research Organization
SOP 408.4 Annex C 20, avenue Appia CH-1211 Geneva 27 Switzerland Tel central +41 22 791 2111 Fax central +41 22 791 3111 www.who.int Part 1: General information WHO PUBLIC INSPECTION REPORT (WHOPIR) Contract
Global Psoriasis Pipeline Drugs Market Assessment: Industry Analysis, Pipeline Review, Clinical Trials, Market Potential Forecast to 2023
Global Psoriasis Pipeline Drugs Market Assessment: Industry Analysis, Pipeline Review, Clinical Trials, Market Potential Forecast to 2023 Global Psoriasis Pipeline Drugs Industry Sizing, Growth and Forecast
HEALTHCARE OF ELDERLY PEOPLE. Will the Minister of HEALTH AND FAMILY WELFARE be pleased to state:
1871. SHRI R. PARTHIPAN: GOVERNMENT OF INDIA MINISTRY OF HEALTH AND FAMILY WELFARE DEPARTMENT OF HEALTH AND FAMILY WELFARE LOK SABHA UNSTARRED QUESTION NO. 1871 TO BE ANSWERED ON 29 TH DECEMBER, 2017 HEALTHCARE
CAREER AIM POSTGRADUATE TRAINING & EXPERIENCE
Dr. Abhishek Parmar DNB. ( CTVS ), MS, MBBS. Consultant. HCG Hospital. AHMEDABAD CAREER AIM I enjoy the enormous responsibility that caring for a critically ill Cardiac and Thoracic patient entails and
Free Trial Future Generics Database
API Atazanavir Structure O 2 C N H O H N OH N NH O N H N CO2 Brand REYATAZ (BMS : World) Indication Antiviral Originator Ciba-Geigy (Novartis) Developer / Licensee BMS Comments Atazanavir is an azapeptide
PDF of Trial CTRI Website URL -
Clinical Trial Details (PDF Generation Date :- Mon, 24 Dec 2018 02:22:00 GMT) CTRI Number Last Modified On 03/07/2018 Post Graduate Thesis Type of Trial Type of Study Study Design Public Title of Study
We are counted among foremost manufacturers, suppliers and exporters of inorganic chemicals and Pharma bulk drugs. To suit various industrial
We are counted among foremost manufacturers, suppliers and exporters of inorganic chemicals and Pharma bulk drugs. To suit various industrial purposes, we avail our entire assortment in IP,BP,USP, GR,
Form IV-A Short-term Inter-State Transactions of Electricity by Trading Licensees ( RTC*)
Form IV-A Short-term Inter- Transactions of Electricity by Trading Licensees ( RTC*) Trading Licensee: Tata Power Trading Co. Ltd. Period of Power Delivery Start date (DD/MM/YYYY) End date (DD/MM/YYYY)
Tender no. 114/TNMSC/ENGG/2013, Dt:
Tender no. 114/TNMSC/ENGG/2013, Dt:06.03.2013. Tender for supply and installation of equipment to 114 NBSU (New Born Stabilization Units) at secondary health care institutions Results of Evaluation of
PDF of Trial CTRI Website URL -
Clinical Trial Details (PDF Generation Date :- Sat, 24 Nov 2018 11:16:02 GMT) CTRI Number CTRI/2010/091/000422 [Registered on: 05/08/2010] - Last Modified On 01/03/2013 Post Graduate Thesis Type of Trial
III) Firms which attended the pre bid conference are as follows: M/s Becton Dickinson India Pvt. Ltd., Gurgaon
Minutes of Pre-bid meeting held on 24/06/2014 at 14:00 hr at RITES office for Supply of CD4 Enumeration Machines against: IFB RITES/MSM/NACP/05/2014 1. The following were present:- I) From RITES S/Shri
Mirage. STRENGTHS 500 Plus Bussiness Associates Plant at Pune, Maharashtra 300 Plus Designs & Shades. PRODUCTION CAPACITY 1,75,000 sq.
MOSAICO Mirage In the diverse world of interior design, it takes a high degree of finesse and a sharp eye for details to rise head and shoulders above the rest. These are the talents, which form the cornerstone
Message from the CEO. Under the One Bright Vision Child Eye Health program of CooperVision, IVI has screened over 53,480 socioeconomically
Message from the CEO The strength of India Vision Institute is the staff who look at what they do with passion and our supporters whose financial help make it possible for us to implement initiatives that
Case 2:09-cv DMC-CCC Document 1 Filed 03/20/2009 Page 1 of 95. Of Counsel:
Case 2:09-cv-01302-DMC-CCC Document 1 Filed 03/20/2009 Page 1 of 95 Charles M. Lizza William C. Baton SAUL EWING LLP One Riverfront Plaza Newark, NJ 07102 (973) 286-6700 clizza@saul.com Attorneys for Plaintiff
REF/2012/08/ CTRI Website URL -
Clinical Trial Details (PDF Generation Date :- Fri, 11 May 2018 23:49:14 GMT) CTRI Number Last Modified On 03/05/2013 Post Graduate Thesis Type of Trial Type of Study Study Design Public Title of Study
Cancer Profile in Patan District, Gujarat: A Comprehensive Review
Cancer Profile in Patan District, Gujarat: A Comprehensive Review Parimal J. Jivarajani*, Prachi K. Shah**, Jayesh B. Solanki***, Himanshu V. Patel***, Vishruti B. Pandya****, Shilin N. Shukla*****, *Associate
Form IV-A Short-term Inter-State Transactions of Electricity by Trading Licensees ( RTC*)
Form IV-A Short-term Inter- Transactions of Electricity by Trading Licensees ( RTC*) Trading Licensee: Tata Power Trading Co. Ltd. Month: April 07 Period of Power Delivery Start date (DD/MM/YYYY) End date